176 related articles for article (PubMed ID: 38148658)
1. Gender dimorphism in hepatocarcinogenesis-DNA methylation modification regulated X-chromosome inactivation escape molecule XIST.
Dai Z; Wang S; Guo X; Wang Y; Yin H; Tan J; Mu C; Sun SH; Liu H; Yang F
Clin Transl Med; 2023 Dec; 13(12):e1518. PubMed ID: 38148658
[TBL] [Abstract][Full Text] [Related]
2. Role of ten-eleven translocation proteins and 5-hydroxymethylcytosine in hepatocellular carcinoma.
Wang P; Yan Y; Yu W; Zhang H
Cell Prolif; 2019 Jul; 52(4):e12626. PubMed ID: 31033072
[TBL] [Abstract][Full Text] [Related]
3. Decrease of 5-hydroxymethylcytosine is associated with progression of hepatocellular carcinoma through downregulation of TET1.
Liu C; Liu L; Chen X; Shen J; Shan J; Xu Y; Yang Z; Wu L; Xia F; Bie P; Cui Y; Bian XW; Qian C
PLoS One; 2013; 8(5):e62828. PubMed ID: 23671639
[TBL] [Abstract][Full Text] [Related]
4. Association of tet methylcytosine dioxygenase 2 and 5-hydroxymethylcytosine in endometrioid adenocarcinoma and its clinical significance.
Kuang L; Zhang J; Li Y; Wang Q; Liu J; Zhang B
BMC Womens Health; 2024 Mar; 24(1):188. PubMed ID: 38515066
[TBL] [Abstract][Full Text] [Related]
5. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma.
Tsang DP; Wu WK; Kang W; Lee YY; Wu F; Yu Z; Xiong L; Chan AW; Tong JH; Yang W; Li MS; Lau SS; Li X; Lee SD; Yang Y; Lai PB; Yu DY; Xu G; Lo KW; Chan MT; Wang H; Lee TL; Yu J; Wong N; Yip KY; To KF; Cheng AS
J Pathol; 2016 Apr; 238(5):651-64. PubMed ID: 26800240
[TBL] [Abstract][Full Text] [Related]
6. Induction of active demethylation and 5hmC formation by 5-azacytidine is TET2 dependent and suggests new treatment strategies against hepatocellular carcinoma.
Sajadian SO; Ehnert S; Vakilian H; Koutsouraki E; Damm G; Seehofer D; Thasler W; Dooley S; Baharvand H; Sipos B; Nussler AK
Clin Epigenetics; 2015; 7(1):98. PubMed ID: 26366235
[TBL] [Abstract][Full Text] [Related]
7. Hepatic cyclooxygenase-2 overexpression induced spontaneous hepatocellular carcinoma formation in mice.
Chen H; Cai W; Chu ESH; Tang J; Wong CC; Wong SH; Sun W; Liang Q; Fang J; Sun Z; Yu J
Oncogene; 2017 Aug; 36(31):4415-4426. PubMed ID: 28346420
[TBL] [Abstract][Full Text] [Related]
8. Promoter hypomethylation up-regulates CD147 expression through increasing Sp1 binding and associates with poor prognosis in human hepatocellular carcinoma.
Kong LM; Liao CG; Chen L; Yang HS; Zhang SH; Zhang Z; Bian HJ; Xing JL; Chen ZN
J Cell Mol Med; 2011 Jun; 15(6):1415-28. PubMed ID: 20629990
[TBL] [Abstract][Full Text] [Related]
9. Global DNA 5-Hydroxymethylcytosine and 5-Formylcytosine Contents Are Decreased in the Early Stage of Hepatocellular Carcinoma.
Liu J; Jiang J; Mo J; Liu D; Cao D; Wang H; He Y; Wang H
Hepatology; 2019 Jan; 69(1):196-208. PubMed ID: 30070373
[TBL] [Abstract][Full Text] [Related]
10. Activation of SRY accounts for male-specific hepatocarcinogenesis: Implication in gender disparity of hepatocellular carcinoma.
Liu C; Ren YF; Dong J; Ke MY; Ma F; Monga SPS; Wu R; Lv Y; Zhang XF
Cancer Lett; 2017 Dec; 410():20-31. PubMed ID: 28942012
[TBL] [Abstract][Full Text] [Related]
11. TREM-2 defends the liver against hepatocellular carcinoma through multifactorial protective mechanisms.
Esparza-Baquer A; Labiano I; Sharif O; Agirre-Lizaso A; Oakley F; Rodrigues PM; Zhuravleva E; O'Rourke CJ; Hijona E; Jimenez-Agüero R; Riaño I; Landa A; La Casta A; Zaki MYW; Munoz-Garrido P; Azkargorta M; Elortza F; Vogel A; Schabbauer G; Aspichueta P; Andersen JB; Knapp S; Mann DA; Bujanda L; Banales JM; Perugorria MJ
Gut; 2021 Jul; 70(7):1345-1361. PubMed ID: 32907830
[TBL] [Abstract][Full Text] [Related]
12. [Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma].
Lou C; Yang B; Gao YT; Wang YJ; Nie FH; Yuan Q; Zhang CL; Du Z
Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):831-6. PubMed ID: 19173828
[TBL] [Abstract][Full Text] [Related]
13. Identification by TCGA database search of five genes that are aberrantly expressed and involved in hepatocellular carcinoma potentially via DNA methylation changes.
Matsushita J; Suzuki T; Okamura K; Ichihara G; Nohara K
Environ Health Prev Med; 2020 Jul; 25(1):31. PubMed ID: 32703154
[TBL] [Abstract][Full Text] [Related]
14. Differentially methylated CpG island within human XIST mediates alternative P2 transcription and YY1 binding.
Chapman AG; Cotton AM; Kelsey AD; Brown CJ
BMC Genet; 2014 Sep; 15():89. PubMed ID: 25200388
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus X protein induces EpCAM expression via active DNA demethylation directed by RelA in complex with EZH2 and TET2.
Fan H; Zhang H; Pascuzzi PE; Andrisani O
Oncogene; 2016 Feb; 35(6):715-26. PubMed ID: 25893293
[TBL] [Abstract][Full Text] [Related]
16. Alterations of regulatory factors and DNA methylation pattern in thyroid cancer.
Iancu IV; Botezatu A; Plesa A; Huica I; Fudulu A; Albulescu A; Bostan M; Mihaila M; Grancea C; Manda DA; Dobrescu R; Vladoiu SV; Anton G; Badiu CV
Cancer Biomark; 2020; 28(2):255-268. PubMed ID: 32390600
[TBL] [Abstract][Full Text] [Related]
17. Coordinated activation of DNMT3a and TET2 in cancer stem cell-like cells initiates and sustains drug resistance in hepatocellular carcinoma.
Cheng T; Zhou C; Bian S; Sobeck K; Liu Y
Cancer Cell Int; 2024 Mar; 24(1):110. PubMed ID: 38528605
[TBL] [Abstract][Full Text] [Related]
18. XIST Induced by JPX Suppresses Hepatocellular Carcinoma by Sponging miR-155-5p.
Lin XQ; Huang ZM; Chen X; Wu F; Wu W
Yonsei Med J; 2018 Sep; 59(7):816-826. PubMed ID: 30091314
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus X protein promotes P3 transcript expression of the insulin-like growth factor 2 gene via inducing hypomethylation of P3 promoter in hepatocellular carcinoma.
Tang S; Hu W; Hu J; Wu S; Li J; Luo Y; Cao M; Zhou H; Jiang X
Liver Int; 2015 Feb; 35(2):608-19. PubMed ID: 24423280
[TBL] [Abstract][Full Text] [Related]
20. DNA binding protein A expression and methylation status in hepatocellular carcinoma and the adjacent tissue.
Yasen M; Obulhasim G; Kajino K; Mogushi K; Mizushima H; Tanaka S; Tanaka H; Hino O; Arii S
Int J Oncol; 2012 Mar; 40(3):789-97. PubMed ID: 22159460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
